Explanipedia

The Current Landscape of Repurposed Drugs for Fungal Neglected Tropical Diseases Open

Tahsin Farid, Keyla C Tumas, Heather Stone, Mili Duggal · 2025

P-1486. Comprehensive Approach to <i>Vibrio Vulnificus</i>: Integrating Drug Therapy, Diagnostic Modalities, and Targeted Care for At-Risk Populations Open

Hashem Haj Ebrahimi, Hiyam Ghneim, Tahsin Farid · 2025

Background Vibrio vulnificus (VV), is endemic to warm coastal waters where it causes significant foodborne and aquatic illnesses resulting in high mortality and morbidity. There are no FDA-approved treatments or standard management strateg…

P-173. An Exploration of the Reported Cases of <i>Acanthamoeba</i> Keratitis Open

Nazia Nagi, Tahsin Farid · 2025

Background Acanthamoeba keratitis (AK) is a rare manifestation of infection caused by this ubiquitous protozoan parasite. Treatment is complicated by the absence of FDA approved treatments. Here we aim to review reported cases of AK to ide…

P-123. Unlocking Synergy: Exploring Combination Therapies in Whipple's Disease for Enhanced Clinical Efficacy Open

Hazem K. Ghneim, Hossein Ebrahimi, Reema Charles, Tahsin Farid · 2025

Background Whipple's disease (WD) is a rare chronic multisystemic infection that primarily affects the gastrointestinal tract. There are no FDA-approved treatments for WD. Standard treatment involves prolonged antibiotic regimens that can …

1402. The Landscape of Infections Caused by Rare Bacterial Pathogens Open

Tahsin Farid, Reema Charles, Keyla C Tumas, Heather Stone, Raghavendra Tirupathi · 2023

Background Rare infectious diseases (RIDs) are a significant source of morbidity and mortality1. Most lack approved treatments and it is difficult to perform comprehensive trials on therapeutic efficacy due to their sporadic nature and dis…

Tahsin Farid YOU? Author Swipe